Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBIT: 2009-2011

Historic EBIT for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.3 million.

  • Lexicon Pharmaceuticals' EBIT fell 48.68% to -$33.3 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$114.1 million, marking a year-over-year decrease of 19.20%. This contributed to the annual value of -$114.1 million for FY2011, which is 19.20% down from last year.
  • As of Q4 2011, Lexicon Pharmaceuticals' EBIT stood at -$33.3 million, which was down 29.78% from -$25.7 million recorded in Q3 2011.
  • In the past 5 years, Lexicon Pharmaceuticals' EBIT ranged from a high of -$21.8 million in Q3 2009 and a low of -$33.3 million during Q4 2011.
  • Moreover, its 3-year median value for EBIT was -$24.3 million (2010), whereas its average is -$25.3 million.
  • In the last 5 years, Lexicon Pharmaceuticals' EBIT grew by 1.57% in 2010 and then tumbled by 48.68% in 2011.
  • Over the past 3 years, Lexicon Pharmaceuticals' EBIT (Quarterly) stood at -$22.8 million in 2009, then climbed by 1.57% to -$22.4 million in 2010, then tumbled by 48.68% to -$33.3 million in 2011.
  • Its EBIT stands at -$33.3 million for Q4 2011, versus -$25.7 million for Q3 2011 and -$25.9 million for Q2 2011.